Erucin inhibits osteoclast formation via suppressing cell–cell fusion molecule DC-STAMP without influencing mineralization by osteoblasts
Abstract Objective Erucin (ERN), an isothiocyanate, is derived from the vegetable arugula. Although ERN has antitumor and antioxidant activity, the effect of ERN on osteoclast and osteoblast differentiation is not well documented. In this study, we evaluated the effects of ERN on osteoclast and oste...
Main Authors: | Tomohiro Takagi, Hirofumi Inoue, Shungo Fujii, Nobuyuki Takahashi, Mariko Uehara |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-03-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13104-022-05988-3 |
Similar Items
-
A Lesson Learnt from Food Chemistry—Elevated Temperature Triggers the Antioxidant Action of Two Edible Isothiocyanates: Erucin and Sulforaphane
by: Jakub Cedrowski, et al.
Published: (2020-11-01) -
Fusion Potential of Human Osteoclasts In Vitro Reflects Age, Menopause, and In Vivo Bone Resorption Levels of Their Donors—A Possible Involvement of DC-STAMP
by: Anaïs M. J. Møller, et al.
Published: (2020-09-01) -
Bioprotective Efficacy of Erucin Against 7,12-Dimethylbenz(α)anthracene-Induced Microstructural Changes in Male Wistar Rats
by: Rahul MANNAN, et al.
Published: (2017-05-01) -
Mex3B inhibits DC-STAMP mRNA level and osteoclastogenesis
by: Yan Yang, et al.
Published: (2022-02-01) -
Osteoclast Fusion: Physiological Regulation of Multinucleation through Heterogeneity—Potential Implications for Drug Sensitivity
by: Kent Søe
Published: (2020-10-01)